Abstract
Aim:
To investigate the relationship between 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), a potential link between obesity and type 2 diabetes, and preadipocyte differentiation.
Methods:
Mouse 11 beta-HSD1 siRNA plasmids were transfected into 3T3-L1 preadipocytes (a cell line derived from mouse Swiss3T3 cells that were isolated from mouse embryo), for examination of the effect of targeted 11 beta-HSD1 inhibition on differentiation of 3T3-L1 cells. Differentiation was stimulated with 3-isobutyl-1-methyxanthine, insulin, and dexamethasone. The transcription level of the genes was detected by real-time PCR.
Results:
Lipid accumulation was significantly inhibited in cells transfected with mouse 11 beta-HSD1 siRNA compared with non-transfected 3T3-L1 cells. Fewer lipid droplets were detected in the transfected cells both prior to stimulation and after stimulation with differentiation-inducing reagents. The expression of adipocyte differentiation-associated markers such as lipoprotein lipase and fatty acid synthetase were downregulated in the transfected cells. Similarly, the expression of preadipocyte factor-1, an inhibitor of adipocyte differentiation, was downregulated upon stimulation of differentiation and had no changes in the transfected cells.
Conclusion:
11 beta-HSD1 can promote preadipocyte differentiation. Based on this, we propose that 11 beta-HSD1 may be an important candidate mediator of obesity and obesity-induced insulin resistance.
Similar content being viewed by others
Article PDF
References
Wake DJ, Walker BR . 11 beta-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 2004; 215: 45–54.
Kotelevtsev YV, Holmes MC, Burchell A . 11 beta-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity or stress. Proc Natl Acad Sci USA 1997; 94: 14924–9.
Morton NM, Holmes MC, Fievet C . Improved lipid, lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001; 276: 41293–300.
Walker BR . 11 beta-Hydroxysteroid dehydrogenase type 1 in obesity. Obes Res 2004; 12: 1–3.
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166–70.
Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83–90.
Tomlinson JW, Walker EA, Bujalska IJ, Draper N, La very GG, Cooper MS, et al. 11 β-hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25: 831–66.
Rabbitt EH, Lavery GG, Walker EA, Cooper MS, Stewart PM, Hewison M . Prereceptor regulation of glucocorticoid action by 11 beta-hydroxysteroid dehydrogenase: A novel determinant of cell proliferation. FASEB J 2002; 16: 36–44.
Felmer RN, Clark JA . The gene suicide system ntr/cb1954 causes ablation of differentiated 3t311 adipocytes by apoptosis. Biol Res 2004; 37: 449–60.
Blagoev B, Kmousechmarova I, Nielsen MM, Fernandez MM, Voldby J, Andersen JS, et al. Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature. J Biol Chem 2002; 277: 42011–6.
Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, et al. 11 beta-Hydroxysteroid dehydrogenase type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 2004; 47: 1088–95.
Moisan MP, Edwards CR, Seckl JR . Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene. Mol Endocrinol 1992; 6: 1082–7.
Williams LJ, Lyons V, MacLeod I, Rajan V, Darlington GJ, Poli V, et al. C/ebp regulates hepatic transcription of 11 beta-hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the c/ebp and glucocorticoid signaling pathways. J Biol Chem 2000; 275: 30232–9.
Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11 beta-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 2001; 276: 12629–35.
Yang K, Khalil MW, Strutt BJ, Killinger DW . 11 beta-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol 1997; 60: 247–53.
Lindsay R, Deborah J . Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 2003; 88: 2738–44.
Eijken M, Hewison M, Cooper MS, de Jong FH, Chiba H, Stewart PM, et al. 11 β-hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol Endocrinol 2005; 19: 621–31.
Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, et al. Regulation of 11 β-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004; 12: 9–17.
Bujalska IJ, Walker EA, Hewison M, Stewart PM . A switch in dehydrogenase to reductase activity of 11 β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J. Clin Endocrinol Metab 2002; 87: 1205–10.
Bujalska IJ, Kumar S, Hewison M, Stewart PM . Differentiation of adipose stromal cells: The roles of glucocorticoids and 11 β-hydroxysteroid dehydrogenase. Endocrinology 1999; 140: 3188–96.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by Natural Science Foundation of Jiangsu Province (No bk2007253).
Rights and permissions
About this article
Cite this article
Liu, Y., Sun, Y., Zhu, T. et al. 11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte. Acta Pharmacol Sin 28, 1198–1204 (2007). https://doi.org/10.1111/j.1745-7254.2007.00602.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00602.x
Keywords
This article is cited by
-
Novel small molecule 11β-HSD1 inhibitor from the endophytic fungus Penicillium commune
Scientific Reports (2016)
-
Development of a High-Throughput Cell-Based Assay for 11β-Hydroxysteroid Dehydrogenase Type 1 Using BacMam Technology
Molecular Biotechnology (2008)